alpha-aminopyridine has been researched along with kaempferol in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adeola, SA; Adu, OB; Ajayi, DC; Akinola, IA; Amusan, OT; Arowosegbe, MA; Bello, AO; Ishola, PG; Kanmodi, RI; Lugbe, NE; Obasieke, PE; Ogun, SO; Ogungbe, BF; Ogunleye, AJ; Ogunmola, OJ; Omotuyi, OI; Oyende, FO; Saibu, GM | 1 |
1 other study(ies) available for alpha-aminopyridine and kaempferol
| Article | Year |
|---|---|
Kaempferol as a Potential PAK4 Inhibitor in Triple Negative Breast Cancer: Extra Precision Glide Docking and Free Energy Calculation.
Topics: Acrylamides; Aminopyridines; Catalytic Domain; Female; Humans; Kaempferols; Molecular Docking Simulation; p21-Activated Kinases; Protein Kinase Inhibitors; Triple Negative Breast Neoplasms | 2020 |